FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today reported financial results for the fiscal third quarter ended March 31, 2007. Highlights of the third quarter of fiscal 2007 and other Company initiatives include:
